These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 17146471)
21. A critique of the dopamine hypothesis of schizophrenia and psychosis. Moncrieff J Harv Rev Psychiatry; 2009; 17(3):214-25. PubMed ID: 19499420 [TBL] [Abstract][Full Text] [Related]
22. Does the dopamine hypothesis explain schizophrenia? Lau CI; Wang HC; Hsu JL; Liu ME Rev Neurosci; 2013; 24(4):389-400. PubMed ID: 23843581 [TBL] [Abstract][Full Text] [Related]
23. Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis. Rogers DP; Goldsmith CA Expert Rev Neurother; 2009 Jan; 9(1):47-54. PubMed ID: 19102668 [TBL] [Abstract][Full Text] [Related]
24. Status of the dopaminergic system in post-mortem brain in schizophrenia. Reynolds GP; Czudek C Psychopharmacol Bull; 1988; 24(3):345-7. PubMed ID: 3153492 [No Abstract] [Full Text] [Related]
25. The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Mobascher A; Winterer G Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S51-9. PubMed ID: 18756421 [TBL] [Abstract][Full Text] [Related]
26. Origins and perspectives of schizophrenia research. Faludi G; Dome P; Lazary J Neuropsychopharmacol Hung; 2011 Dec; 13(4):185-92. PubMed ID: 22184186 [TBL] [Abstract][Full Text] [Related]
28. The possible involvement of metabotropic glutamate receptors in schizophrenia. Krivoy A; Fischel T; Weizman A Eur Neuropsychopharmacol; 2008 Jun; 18(6):395-405. PubMed ID: 18063347 [TBL] [Abstract][Full Text] [Related]
29. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Hattori S; Murotani T; Matsuzaki S; Ishizuka T; Kumamoto N; Takeda M; Tohyama M; Yamatodani A; Kunugi H; Hashimoto R Biochem Biophys Res Commun; 2008 Aug; 373(2):298-302. PubMed ID: 18555792 [TBL] [Abstract][Full Text] [Related]
30. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076 [TBL] [Abstract][Full Text] [Related]
31. Interactive memory systems and category learning in schizophrenia. Kéri S Neurosci Biobehav Rev; 2008; 32(2):206-18. PubMed ID: 17854895 [TBL] [Abstract][Full Text] [Related]
32. The kynurenic acid hypothesis of schizophrenia. Erhardt S; Schwieler L; Nilsson L; Linderholm K; Engberg G Physiol Behav; 2007 Sep; 92(1-2):203-9. PubMed ID: 17573079 [TBL] [Abstract][Full Text] [Related]
34. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development. Marek GJ Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861 [TBL] [Abstract][Full Text] [Related]
35. Role of muscarinic receptors in the pathology of schizophrenia. Dean B Am J Med Genet B Neuropsychiatr Genet; 2004 Apr; 126B(1):8-9. PubMed ID: 15048640 [No Abstract] [Full Text] [Related]
36. Evolution of schizophrenia drugs: a focus on dopaminergic systems. Nikam SS; Awasthi AK Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530 [TBL] [Abstract][Full Text] [Related]